Sleep dysfunction in patients with cancer

Current Treatment Options in Neurology

Volumn 9, Issue 5, 2007, Pages 337-346

  Fiorentino, Lavinia ^a   Ancoli Israel, Sonia ^a  

^a UNIVERSITY OF SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CIMETIDINE; CYTOKINE; ESZOPICLONE; FLUCONAZOLE; FLUVOXAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOCONAZOLE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; PSYCHOTROPIC AGENT; RAMELTEON; RIFAMPICIN; ZALEPLON; ZOLPIDEM;

ACTIMETRY; ALCOHOLIC BEVERAGE; AMNESIA; ANXIETY; ATAXIA; BONE METASTASIS; BREAST CANCER; CANCER; CANCER PAIN; CANCER PATIENT; CHRONOTHERAPY; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; COORDINATION DISORDER; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DEPRESSION; DIARRHEA; DISTRESS SYNDROME; DIZZINESS; DROWSINESS; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG INHIBITION; EUPHORIA; EVIDENCE BASED MEDICINE; FATIGUE; FOOD DRUG INTERACTION; HALLUCINATION; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INFLAMMATION; INSOMNIA; LIPID DIET; LOW DRUG DOSE; MEMORY DISORDER; MYALGIA; NAUSEA; PATHOGENESIS; POLYSOMNOGRAPHY; PREVALENCE; REM SLEEP; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP TIME; SLOW WAVE SLEEP; SOMNOLENCE; STOMACH PAIN; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; VOMITING;

EID: 34548510109     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-007-0019-0     Document Type: Review

References (47)

1. Ancoli-Israel S, Moore P, Jones V: The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 2001, 10:245-255.
2. Savard J, Morin CM: Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001, 19:895-908.
3. Fiorentino L, Ancoli-Israel S: Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006, 10:419-429.
4. Nesse W, Hoekema A, Stegenga B, et al.: Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol 2006, 42:108-114.
5. Berger AM, Parker KP, Young-McCaughan S, et al.: Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 2005, 32:E98-E126.
6. Cimprich B: Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 1999, 22:185-194.
7. Engstrom CA, Strohl RA, Rose L, et al.: Sleep alterations in cancer patients. Cancer Nurs 1999, 22:143-148.
8. Anderson KO, Getto QJ, Mendoza TR, et al.: Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 2003, 25:307-318.
9. Sela RA, Watanabe S, Nekolaichuk CL: Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 2005, 3:23-31.
10. Davidson JR, MacLean AW, Brundage MD, Schulze K: Sleep disturbance in cancer patients. Soc Sci Med 2002, 54:1309-1321.
11. Holland JC, Plumb M: A comparative study of depressive symptoms in patients with advanced cancer. Proc Am Assoc Cancer Res 1977, 18:201.
12. Savard J, Simard S, Blanchet J, et al.: Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001, 24:583-590.
13. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr PP: Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993, 11:997-1004.
14. Ancoli-Israel S: Sleep and fatigue in cancer patients. In Principles and Practice of Sleep Medicine. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: WB Saunders; 2005:1218-1224.
15. Fiorentino L, Mason W, Parker B, et al.: Sleep disruption in breast cancer patients post-chemotherapy. Sleep 2005, 28:A294.
16. Savard J, Simard S, Ivers H, Morin CM: Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005, 23:6083-6096.
17. Savard J, Davidson JR, Ivers H, et al.: The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 2004, 27:513-522.
18. Ancoli-Israel S, Cole R, Alessi CA, et al.: The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26:342-392.
19. Miaskowski C, Lee KA: Pain, fatigue and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999, 17:320-332.
20. Payne JK, Piper B, Rabinowitz I, Zimmerman B: Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum 2006, 33:775-783.
21. Ancoli-Israel S, Liu L, Matter M, et al.: Fatigue, sleep and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006, 14:201-209.
22. Liu L, Parker B, Dimsdale J, et al.: Pre-treatment subjective sleep quality predicts fatigue, mood, and quality of life in breast cancer patients during chemotherapy. Sleep 2006, 29(Suppl):A309.
23. Palesh OG, Collie K, Batiuchok D, et al.: A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007, 75:37-44.
24. Speilman AJ, Glovinsky PB: Case studies in insomnia. In The Varied Nature of Insomnia. Edited by Hauri PJ. New York: Plenum Press; 1991:1-15.
25. Hu D, Silberfarb PM: Management of sleep problems in cancer patients. Oncology 1991, 5:23-27.
26. Lewin DS, Dahl RE: Importance of sleep in the management of pediatric pain. J Dev Behav Pediatr 1999, 20:244-252.
27. Dimsdale JE, Norman D, DeJardin D, Wallace MS: The effect of opioids on sleep architecture. J Clin Sleep Med 2007, 3:33-36.
28. Lee K, Cho M, Miaskowski C, Dodd M: Impaired sleep and rhythms in persons with cancer. Sleep Med Rev 2004, 8:199-212.
29. Moser M, Schaumberger K, Schernhammer E, Stevens RG: Cancer and rhythm. Cancer Causes Control 2006, 17:483-487.
30. Mormont MC, Waterhouse J, Bleuzen P, et al.: Marked 24-h rest/ activity rhythms are associated with better quality of life, better response and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6:3038-3045.
31. Liu L, Marler M, Parker BA, et al.: The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer 2005, 13:1010-1017.
32. Levi F: Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 2006, 17:611-621.
33. Wood PA, Hrushesky WJM: Circadian rhythms and cancer chemotherapy. Crit Rev Eukaryot Gene Expr 1996, 6:299-343.
34. Rich T, Innominato PF, Boerner J, et al.: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005, 11:1757-1764.
35. Lee BN, Dantzer R, Langley KE, et al.: A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 2004, 11:279-292.
36. Vgontzas AN, Pejovic S, Zoumakis E, et al.: Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. Am J Physiol Endocrinol Metab 2006, 292:E253-E261.
37. Mills PJ, Parker BA, Dimsdale JE, et al.: The relationship between fatigue, quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 2005, 69:85-96.
38. Mills PJ, Parker BA, Jones V, et al.: The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res 2004, 10:4998-5003.
39. Savard J, Simard S, Ivers H, Morin CM: Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol 2005, 23:6097-6106.
40. Kelley KW, Bluthe RM, Dantzer R, et al.: Cytokine-induced sickness behavior. Brain Behav Immun 2003, 17: S112-S118.
41. Derogatis LR, Feldstein M, Morrow G, et al.: A survey of psychotropic drug prescriptions in an oncology population. Cancer 1979, 44:1919-1929.
42. Stiefel FC, Kornblith AB, Holland JC: Changes in the prescription patterns of psychotropic drugs over a 10-year period. Cancer 1990, 65:1048-1053.
43. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005, 28:1049-1058.
44. Bastien CH, Morin CM, Ouellet MC, et al.: Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations. J Consult Clin Psychol 2004, 72:653-659.
45. Quesnel C, Savard J, Simard S, et al.: Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol 2003, 71:189-200.
46. Morin CM, Colecchi C, Stone J, et al.: Behavioral and pharmacological therapies for late life insomnia. JAMA 1999, 281:991-999.
47. Theobald DE: Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004, 6:S15-S21.